4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with sq 29548 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GG; Hsin, MK; Huang, RY; Li, MY; Ma, LT; Mok, TS; Underwood, MJ; Warner, TD | 1 |
1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and sq 29548
| Article | Year |
|---|---|
4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinogens; Cell Growth Processes; Cell Survival; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Fatty Acids, Unsaturated; Humans; Hydrazines; Lung Neoplasms; Nitrosamines; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Thromboxane A2, Prostaglandin H2; Smoking; Thromboxane A2; Thromboxane-A Synthase; Tumor Cells, Cultured | 2011 |